Loperamide hydrochloride capsule is indicated for the control and symptomatic relief of acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel disease.

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad (India).

Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of USD 34.7 mn in the United States (IQVIA MAT, January 2023).